Rise in Collaborations Aiding Biosimilar Development
Giant pharmaceutical players have increased their focused towards partnership agreements in a move to lower down the healthcare service expenditure. This will in a way support the effective and efficient development of biosimilars as well as provide players with first mover’s advantage in the market once the biologic’s patent get expired. Such pace of significant collaborations will not only strengthen companies to hold a dominant share in biosimilar market but will also expand their presence across nations. For instance, Baxter...
View full press release